OPNT - OPNET Technologies Inc.

OPNT Stock Chart

OPNT Profile

Opiant Pharmaceuticals, Inc., headquartered in Santa Monica, California, is a specialized pharmaceutical company dedicated to developing treatments for addictions and drug overdose. Since its inception in 2005, Opiant has focused on advancing innovative medicines aimed at addressing critical public health challenges.

The company's flagship product, NARCAN nasal spray, represents a vital intervention for reversing opioid overdoses, offering rapid and effective administration in emergency situations. Opiant continues to enhance its portfolio with a robust pipeline of product candidates targeting various therapeutic areas including opioid overdose reversal, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders.

Formerly known as Lightlake Therapeutics Inc., Opiant Pharmaceuticals rebranded in January 2016 to reflect its expanded focus and commitment to combating addiction and overdose through cutting-edge pharmaceutical solutions. The company leverages its scientific expertise and strategic partnerships to accelerate the development and commercialization of novel therapies.

Driven by a mission to improve patient outcomes and public health outcomes, Opiant Pharmaceuticals remains at the forefront of pharmaceutical innovation. With a comprehensive approach to addressing substance use disorders, the company continues to explore new avenues for therapeutic advancement, underscoring its role as a leader in addiction medicine.

OPNT Revenue Chart

OPNT Earnings

Analyst Ratings